Search results for: “keytruda”
-
Blog
Keytruda Receives 40th FDA Approval
This week marked a significant milestone in the fight against cancer. On June 17, the FDA approved… -
Blog
FDA approves Keytruda combo for first-line lung cancer treatment
Patients in the U.S. who have advanced nonsquamous non-small cell lung cancer can now receive Keytruda as…
-
Blog
Pembrolizumab (Keytruda®) Approved as First-Line Option for Lung Cancer
Anti-PD-1 checkpoint antibody is the only immunotherapy approved for first-line treatment for lung cancer patients.
-
Blog
FDA Approves Pembrolizumab (Keytruda®), a PD-1 Antibody, for Head and Neck Cancer
New hope now exists for patients with advanced head and neck cancer.
-
Blog
European Regulators Approve Pembrolizumab (Keytruda) as First-line Treatment of Advanced Melanoma
The decision makes pembrolizumab the second PD-1-blocking drug to receive approval in Europe.
-
Story
From Terminal to Thriving: Gordon’s Immunotherapy Journey
After exhausting nearly every treatment option for stage 4 colorectal cancer, Gordon Levine was preparing to put… -
Story
How This Sales Exec Talked Her Way Into the Clinical Trial That Saved Her Life
Adrienne Skinner’s journey began with vigilance — years of regular screenings after learning she had Lynch syndrome… -
Blog
A Rare Cancer and the Clinical Trial That Saved Her Life
Due to her Lynch syndrome, Adrienne Skinner was vigilant about routine cancer screenings. Lynch syndrome significantly increases… -
Blog
Cervical Cancer and Immunotherapy: What Patients Should Know
A cervical cancer diagnosis can bring uncertainty, fear, and a lot of questions. If you or someone…